Zero deaths from tuberculosis: progress, reality, and hope

Lancet Infect Dis. 2013 Apr;13(4):285-7. doi: 10.1016/S1473-3099(13)70039-2. Epub 2013 Mar 24.
No abstract available

Publication types

  • Introductory Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / microbiology
  • Antitubercular Agents* / pharmacology
  • Antitubercular Agents* / therapeutic use
  • Communicable Diseases
  • Health Policy
  • Humans
  • Mycobacterium tuberculosis / drug effects*
  • Point-of-Care Systems
  • Rifampin
  • Tuberculosis Vaccines / administration & dosage
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology

Substances

  • Antitubercular Agents
  • Tuberculosis Vaccines
  • Rifampin